HIV - 1 protease - wikipedia HIV - 1 protease HIV - 1 Protease ( Retropepsin ) HIV - 1 protease dimer in white and grey, with peptide substrate in black and active site aspartate side chains in red. ( PDB : 1KJF ​ ) Identifiers EC number 3.4. 23.16 CAS number 144114 - 21 - 6 Databases IntEnz IntEnz view BRENDA BRENDA entry ExPASy NiceZyme view KEGG KEGG entry MetaCyc metabolic pathway PRIAM profile PDB structures RCSB PDB PDBe PDBsum Gene Ontology AmiGO / QuickGO Search PMC articles PubMed articles NCBI proteins HIV - 1 protease is a retroviral aspartyl protease ( retropepsin ) that is essential for the life - cycle of HIV, the retrovirus that causes AIDS. HIV protease cleaves newly synthesized polyproteins ( namely, Gag and Gag - Pol ) at the appropriate places to create the mature protein components of an infectious HIV virion. Without effective HIV protease, HIV virions remain uninfectious. Thus, mutation of HIV protease 's active site or inhibition of its activity disrupts HIV 's ability to replicate and infect additional cells, making HIV protease inhibition the subject of considerable pharmaceutical research. Contents 1 Structure and function 2 HIV - 1 protease as a drug target 3 See also 4 External links 5 References Structure and function HIV - 1 protease labelled according to its resemblance to an English Bulldog or a fat cat. The blue and cyan - green ribbons depict the peptide backbone of a wild - type ( 1D4S ​ ) and a mutant ( 1KZK ​ ) structure, respectively. HIV protease 's protein structure has been investigated using X-ray crystallography. It exists as a homodimer, with each subunit made up of 99 amino acids. The active site lies between the identical subunits and has the characteristic Asp - Thr - Gly ( Asp25, Thr26 and Gly27 ) sequence common to aspartic proteases. The two Asp25 residues ( one from each chain ) act as the catalytic residues. According to the mechanism for HIV protease protein cleavage proposed by Mariusz Jaskolski and colleagues, water acts as a nucleophile, which acts in simultaneous conjunction with a well - placed aspartic acid to hydrolyze the scissile peptide bond. Additionally, HIV protease has two molecular `` flaps '' which move a distance of up to 7 Å when the enzyme becomes associated with a substrate. HIV - 1 protease as a drug target The HIV - 1 protease dimer ( green and cyan ) with active site Asp - 25 in red. Complexed with a polypeptide substrate ( magenta ). ( PDB : 1KJF ​ ) Complexed with inhibitor BEA369 ( depicted as a sticks with carbon in white, nitrogen in blue, oxygen in red ). ( PDB : 1EBY ​ ) With its integral role in HIV replication, HIV protease has been a prime target for drug therapy. HIV protease inhibitors work by specifically binding to the active site by mimicking the tetrahedral intermediate of its substrate and essentially becoming `` stuck, '' disabling the enzyme. After assembly and budding, viral particles lacking active protease can not mature into infectious virions. Several protease inhibitors have been licensed for HIV therapy. HIV - 1 Protease has the classic AspThrGly of Aspartyl Proteases. These amino acids are located at position 25, 26, and 27, and are responsible for the catalytic activity. However, due to the high mutation rates of retroviruses, and considering that changes to a few amino acids within HIV protease can render it much less visible to an inhibitor, the active site of this enzyme can change rapidly when under the selective pressure of replication - inhibiting drugs. One approach to minimizing the development of drug - resistance in HIV is to administer a combination of drugs which inhibit several key aspects of the HIV replication cycle simultaneously, rather than one drug at a time. Other drug therapy targets include reverse transcriptase, virus attachment, membrane fusion, cDNA integration and virion assembly. See also Management of HIV / AIDS Discovery and development of HIV - protease inhibitors External links The MEROPS online database for peptidases and their inhibitors : A02. 001 Proteopedia HIV - 1_protease - the HIV - 1 protease structure in interactive 3D HIV - 1 Protease at the US National Library of Medicine Medical Subject Headings ( MeSH ) References ^ Jump up to : Davies DR ( 1990 ). `` The structure and function of the aspartic proteinases ''. Annu Rev Biophys Biophys Chem. 19 ( 1 ) : 189 -- 215. PMID 2194475. doi : 10.1146 / annurev. bb. 19.060190. 001201. Jump up ^ Brik A, Wong CH ( January 2003 ). `` HIV - 1 protease : mechanism and drug discovery ''. Org. Biomol. Chem. 1 ( 1 ) : 5 -- 14. PMID 12929379. doi : 10.1039 / b208248a. Jump up ^ Huang, X ; Britto, MD ; Kear - Scott, JL ; Boone, CD ; Rocca, JR ; Simmerling, C ; Mckenna, R ; Bieri, M ; Gooley, PR ; Dunn, BM ; Fanucci, GE ( 13 June 2014 ). `` The role of select subtype polymorphisms on HIV - 1 protease conformational sampling and dynamics. ''. The Journal of Biological Chemistry. 289 ( 24 ) : 17203 -- 14. PMC 4059161. PMID 24742668. doi : 10.1074 / jbc. M114. 571836. Jump up ^ Kräusslich HG, Ingraham RH, Skoog MT, Wimmer E, Pallai PV, Carter CA ( February 1989 ). `` Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides ''. Proc. Natl. Acad. Sci. U.S.A. 86 ( 3 ) : 807 -- 11. PMC 286566. PMID 2644644. doi : 10.1073 / pnas. 86.3. 807. Jump up ^ Kohl NE, Emini EA, Schleif WA, et al. ( July 1988 ). `` Active human immunodeficiency virus protease is required for viral infectivity ''. Proc. Natl. Acad. Sci. U.S.A. 85 ( 13 ) : 4686 -- 90. PMC 280500. PMID 3290901. doi : 10.1073 / pnas. 85.13. 4686. Jump up ^ Seelmeier S, Schmidt H, Turk V, von der Helm K ( September 1988 ). `` Human immunodeficiency virus has an aspartic - type protease that can be inhibited by pepstatin A ''. Proc. Natl. Acad. Sci. U.S.A. 85 ( 18 ) : 6612 -- 6. PMC 282027. PMID 3045820. doi : 10.1073 / pnas. 85.18. 6612. Jump up ^ McPhee F, Good AC, Kuntz ID, Craik CS ( October 1996 ). `` Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation ''. Proc. Natl. Acad. Sci. U.S.A. 93 ( 21 ) : 11477 -- 81. PMC 56635. PMID 8876160. doi : 10.1073 / pnas. 93.21. 11477. Jump up ^ Perryman AL, Lin JH, McCammon JA ( April 2004 ). `` HIV - 1 protease molecular dynamics of a wild - type and of the V82F / I84V mutant : possible contributions to drug resistance and a potential new target site for drugs '' ( PDF ). Protein Sci. 13 ( 4 ) : 1108 -- 23. PMC 2280056. PMID 15044738. doi : 10.1110 / ps. 03468904. Retrieved 2008 - 06 - 27. Jump up ^ Jaskólski M, Tomasselli AG, Sawyer TK, Staples DG, Heinrikson RL, Schneider J, Kent SB, Wlodawer A ( February 1991 ). `` Structure at 2.5 - A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene - based inhibitor ''. Biochemistry. 30 ( 6 ) : 1600 -- 9. PMID 1993177. doi : 10.1021 / bi00220a023. Jump up ^ Miller M, Schneider J, Sathyanarayana BK, Toth MV, Marshall GR, Clawson L, Selk L, Kent SB, Wlodawer A ( December 1989 ). `` Structure of complex of synthetic HIV - 1 protease with a substrate - based inhibitor at 2.3 A resolution ''. Science. 246 ( 4934 ) : 1149 -- 52. PMID 2686029. doi : 10.1126 / science. 2686029. Jump up ^ H.P. Rang ( 2007 ). Rang and Dale 's pharmacology ( 6th ed. ). Philadelphia, Pa., U.S.A. : Churchill Livingstone / Elsevier. ISBN 9780808923541. Jump up ^ Watkins T, Resch W, Irlbeck D, Swanstrom R ( February 2003 ). `` Selection of high - level resistance to human immunodeficiency virus type 1 protease inhibitors ''. Antimicrob. Agents Chemother. 47 ( 2 ) : 759 -- 69. PMC 151730. PMID 12543689. doi : 10.1128 / AAC. 47.2. 759 - 769.2003. Jump up ^ Moore JP, Stevenson M ( October 2000 ). `` New targets for inhibitors of HIV - 1 replication ''. Nat. Rev. Mol. Cell Biol. 1 ( 1 ) : 40 -- 9. PMID 11413488. doi : 10.1038 / 35036060. Jump up ^ De Clercq E ( December 2007 ). `` The design of drugs for HIV and HCV ''. Nat Rev Drug Discov. 6 ( 12 ) : 1001 -- 18. PMID 18049474. doi : 10.1038 / nrd2424. HIV / AIDS topics HIV / AIDS HIV HIV structure and genome subtypes CDC classification disease progression rates HIV / AIDS diagnosis management pathophysiology prevention research vaccination PrEP WHO disease staging system for HIV infection and disease Children Teens / Adults Countries by AIDS prevalence rate Conditions Signs and symptoms AIDS - defining clinical condition Diffuse infiltrative lymphocytosis syndrome Lipodystrophy Nephropathy Neurocognitive disorders Pruritus Superinfection Tuberculosis co-infection HIV Drug Resistance Database Innate resistance to HIV History History Epidemiology Multiple sex partners Timeline AIDS Museum Timothy Ray Brown Social AIDS orphan Catholic Church and HIV / AIDS Circumcision and HIV Criminal transmission Discrimination against people Economic impact HIV - affected community HIV / AIDS denialism Safe sex Sex education List of HIV - positive people People With AIDS Self - Empowerment Movement Culture International AIDS Conference International AIDS Society Joint United Nations Programme on HIV / AIDS ( UNAIDS ) President 's Emergency Plan for AIDS Relief ( PEPFAR ) Treatment Action Campaign World AIDS Day Media portrayal of HIV / AIDS Misconceptions about HIV / AIDS Discredited HIV / AIDS origins theories AIDS pandemic by region / country Africa Angola Benin Botswana Democratic Republic of the Congo Egypt Ethiopia Ghana Guinea Côte d'Ivoire ( Ivory Coast ) Kenya Lesotho Madagascar Malawi Mali Mozambique Namibia Niger Nigeria Rwanda Senegal Swaziland Tanzania South Africa Uganda Zambia Zimbabwe North America Canada Mexico El Salvador Guatemala Honduras Nicaragua United States New York City Caribbean Haiti Jamaica Dominican Republic South America Bolivia Brazil Colombia Guyana Peru Asia Bangladesh Bhutan Myanmar ( Burma ) Cambodia China ( PRC ) ( Yunnan ) East Timor India Indonesia Iraq Japan Jordan Laos Nepal North Korea Pakistan Philippines Thailand Taiwan ( ROC ) United Arab Emirates Vietnam Europe United Kingdom Russia Ukraine Oceania Australia New Zealand Papua New Guinea List of countries by HIV / AIDS adult prevalence rate List of HIV / AIDS cases and deaths registered by region Viral proteins ( early and late ) DNA Herpes simplex Herpes simplex virus protein vmw65 HHV capsid portal protein Hepatitis B HBsAg HBcAg HBeAg HBx Hepatitis B virus DNA polymerase Epstein -- Barr EBNA - 1 EBNA - 2 EBNA - 3 LMP - 1 LMP - 2 EBER RNA Rotavirus VNPs : NSP1 NSP2 NSP4 NSP5 NSP6 Influenza capsid : matrix protein M1 protein viral envelope M2 protein glycoprotein : Influenza hemagglutinin Neuraminidase Parainfluenza Parainfluenza hemagglutinin - neuraminidase Mumps Mumps hemagglutinin - neuraminidase Measles Measles hemagglutinin RSV Respiratory syncytial virus G protein Hepatitis C VSPs : E1 E2 VNPs : P7 NS2 NS3 NS4A NS4B NS5A NS5B RT Structure and genome of HIV VSPs : gag pol Integrase Reverse transcriptase HIV - 1 protease env gp120 gp41 VRAPs : transactivators Tat Rev Vpr Nef Vif Vpu Fusion protein Gag - onc fusion protein Proteases : aspartate proteases ( EC 3.4. 23 ) Vertebrate Pepsin Chymosin Renin Signal peptide peptidase Beta secretase Pathogenic Plasmepsin HIV - 1 protease Plant Nepenthesin Cathepsin Enzymes Activity Active site Binding site Catalytic triad Oxyanion hole Enzyme promiscuity Catalytically perfect enzyme Coenzyme Cofactor Enzyme catalysis Regulation Allosteric regulation Cooperativity Enzyme inhibitor Classification EC number Enzyme superfamily Enzyme family List of enzymes Kinetics Enzyme kinetics Eadie -- Hofstee diagram Hanes -- Woolf plot Lineweaver -- Burk plot Michaelis -- Menten kinetics Types EC1 Oxidoreductases ( list ) EC2 Transferases ( list ) EC3 Hydrolases ( list ) EC4 Lyases ( list ) EC5 Isomerases ( list ) EC6 Ligases ( list ) Molecular and Cellular Biology portal Retrieved from `` https://en.wikipedia.org/w/index.php?title=HIV-1_protease&oldid=793350184 '' Categories : HIV / AIDS EC 3.4. 23 Peptidase Enzymes of known structure Talk Search Contents About Wikipedia Deutsch Español فارسی Polski Русский Slovenščina Српски / srpski Srpskohrvatski / српскохрватски Edit links This page was last edited on 1 August 2017, at 06 : 20. Text is available under the Creative Commons Attribution - ShareAlike License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia ® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. About Wikipedia

Question: hiv protease uses _ side chains at its active site
Answer: aspartate